Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.
ActiveOn, a company specializing in cosmetic materials and microcapsules, including preservative alternatives, spares no effort to share happiness with neighbors, with the objective that happy employees generate the greatest goods.
RideFlux Inc. is a South Korean company that specializes in developing self-driving technology for automobiles. Founded in 2018 and headquartered on Jeju Island, the company aims to create safe and reliable autonomous transportation services. Jeju Island offers a diverse range of road environments and weather conditions, making it an ideal location for testing and enhancing autonomous driving software. RideFlux focuses on providing innovative solutions that improve the driving experience, emphasizing safety and efficiency in transportation. The company's offerings include autonomous driving software, remote control services, and high-precision mapping solutions, all designed to meet the growing demand for mobility services in urban environments. Through its advancements in self-driving technology, RideFlux aspires to contribute to a future where transportation is safer and more comfortable for everyone.
Microbiotix
Series B in 2024
MicrobiotiX is a biotechnology company focused on developing innovative therapeutics that utilize bacteriophages and the microbiome to address multidrug-resistant infections and autoimmune diseases. The company's platform incorporates safe gastrointestinal microbiota transplants and formulates fecal microbiota transplant capsules for oral administration. By researching and developing effective bacteriophage therapies, MicrobiotiX aims to provide convenient and economical treatment options for patients, enhancing the healthcare sector's ability to combat challenging medical conditions.
Bio Design Lab
Series B in 2024
Bio Design Lab is a biotechnology company focused on the development of biopharmaceutical products, specifically in the areas of gene, cell, and immunotherapies. The company employs systems-level genetic and genomic design strategies to create potent drugs aimed at addressing a range of diseases. By utilizing advanced methodologies, Bio Design Lab aims to enhance the efficiency of drug development processes for healthcare organizations, ultimately contributing to the creation of effective therapeutic solutions.
Firmmit is a technology-focused agricultural company specializing in optimizing growth data through secure analysis of agricultural technology information. It operates by providing container farms and hydroponic systems for crop cultivation without soil, using less water than traditional methods. This enables both commercial farmers and home growers to efficiently utilize resources and maximize production capabilities, promoting sustainable farming practices and enhanced crop yields.
AIDIN ROBOTICS
Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.
Inter X is an industrial AI and big data analysis company.
EYEQ Lab is an engineering service company specializing in the development of power semiconductors. The company aims to revolutionize the power semiconductor industry by leveraging the expertise and advanced technologies of its skilled team. EYEQ Lab's semiconductor applications span various sectors, including solar energy, autonomous vehicles, high-speed battery chargers, medical equipment, and aerospace. Through its innovative solutions, EYEQ Lab enables customers to stay at the forefront of power semiconductor technology.
LiveIn is a leading online marketplace specializing in student accommodation, boasting over 20,000 listings. The company operates a real estate brokerage platform designed to assist young individuals with limited economic resources in finding affordable rental housing. LiveIn prioritizes the well-being of its clients and workers, ensuring a responsible approach to their services. The platform provides a seamless rental search experience, featuring fully furnished rooms equipped with complimentary WiFi, weekly housekeeping, and maintenance services. This enables customers to easily locate and book rental properties in their vicinity, making the process efficient and user-friendly.
Juexin Technology
Series B in 2024
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.
DYNE Medical Group
Series B in 2024
DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.
​Orange Square
Series B in 2024
​Orange Square is a fintech platform that offers prepaid cards and mobile wallets for travelers.
Getcha is a comprehensive car purchasing and rental service that operates an online comparison shopping platform. The company facilitates the buying process by connecting consumers with sellers and providing access to a network of dealerships. Getcha enables users to obtain multiple price quotes, ensuring transparency in transaction pricing. In addition to car purchases, the company offers long-term rentals, leasing options, test rides, and car consulting services, catering to a wide range of automotive needs. By streamlining the car buying experience, Getcha empowers customers with the information they need to make informed decisions while allowing sellers to focus on motivated buyers.
CareMedi is a healthcare company specializing in the development of innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company's platform offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers. By enabling consumers to conveniently order these products from home, CareMedi aims to improve overall lifestyle and health outcomes for its users.
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience
Jenfi
Funding Round in 2023
Jenfi is a financial technology company founded by Jeffrey Liu and Justin Louie, specializing in revenue-based financing for digital-native businesses in Southeast Asia. The company offers a service known as Growth Capital as a Service (GCaaS), which provides non-dilutive capital of up to US$1,000,000 to help businesses scale their marketing, inventory, and growth initiatives. Jenfi utilizes a proprietary risk assessment engine to evaluate both the creditworthiness of businesses and their marketing growth efficiency, ensuring that financing options are flexible and customized to meet the specific needs of each client. The platform has supported hundreds of digital-native companies, including various B2B and SaaS startups. Prior to founding Jenfi, Liu and Louie successfully developed and exited the fitness subscription service GuavaPass.
S-Alpha Therapeutics
Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.
VSI is a manufacturer of semiconductors specializing in automotive networking technologies. The company develops essential networking solutions aimed at next-generation automotive and industrial applications, with a particular focus on supporting the needs of autonomous vehicles. By providing innovative products that enhance vehicle connectivity, VSI plays a crucial role in advancing the automotive industry and meeting the demands of modern car manufacturers.
Kneader operates an online recruitment service specializing in temporary and part-time job matching. Employers can post vacancies, browse candidate profiles, and hire individuals using Kneader's career management services. Job seekers can create detailed profiles highlighting their skills, education, and experience, and apply for suitable positions.
Innospace
Series B in 2022
Innospace Co Ltd is an aerospace and defense company that specializes in the development and provision of launch services for small satellites. The company focuses on creating hybrid rocket-powered small satellite launch vehicles, which are designed to deliver low-cost, low-latency, and eco-friendly launch solutions. By leveraging innovative technology, Innospace aims to establish a reliable presence in the small satellite market, offering services that meet the growing demands of satellite deployment while emphasizing sustainable practices.
NRISE is a company focused on developing innovative software applications that enhance communication and content sharing among users. It offers a range of services, including MOCI and WIPPY, which are designed to facilitate connections between individuals and provide access to diverse content. In addition to social media services, NRISE has created an application specifically for home workouts, integrating fitness with social interaction. Through these applications, the company aims to bring users the joy of communication while promoting engagement with various types of content.
SuperBin Co., founded in 2015 and headquartered in Seongnam-si, South Korea, specializes in the development of Nephron, an advanced circular resources collection robot. This innovative robot employs artificial intelligence to autonomously identify, sort, collect, and process waste materials, specifically targeting plastics and aluminum cans. SuperBin aims to foster a culture of recycling and sustainable growth by incentivizing users with financial rewards for their recycling efforts. Through its technology, the company seeks to promote the value of circulating resources and encourage a collective commitment to environmental responsibility.
Oncobix is a drug development company focused on creating innovative treatments for rare and incurable diseases that are difficult to address with current medical practices. The company has developed a novel compound, represented by a specific chemical formula or its salts, along with a pharmaceutical composition aimed at treating conditions such as lung cancer. By prioritizing the well-being of patients, Oncobix seeks to provide new therapeutic options that can significantly impact the treatment landscape for challenging medical conditions.
Apposter is a South Korean interactive solutions company that specializes in UI development, app development, and mobile business consultancy. The company has created several mobile applications for the enterprise market, including Fotofly, Life Valley, and Tok Song. In addition to its core offerings, Apposter has developed a platform for smartwatch faces, allowing users to create and customize watch faces quickly and easily. The company also designs, manufactures, and sells a variety of tech accessories, including watches suitable for both men and women. Through its innovative solutions, Apposter enables clients to craft unique watch faces and share them with a global audience.
21gram is a company that specializes in pet funeral services, focusing on connecting pet owners with reputable companion animal funeral homes. It offers a platform that allows users to search for and book services based on location, costs, and specific requirements. Additionally, 21gram provides counseling services to assist customers in navigating the process of honoring their pets after passing. By streamlining the search for pet funeral homes and ensuring a respectful farewell, the company aims to support pet owners during a challenging time.
Gitple is a technology company that develops an interactive customer support platform, offering customer experience as a cloud service. Its platform enables businesses to integrate customer service functionality into mobile applications, facilitating collaborative responses from chatbots and agents, thereby enhancing brand image and driving sales.
Genesis Lab
Series B in 2022
Genesis Lab, Inc. is a technology company based in Seoul, South Korea, founded in 2017, specializing in the development of artificial intelligence behavior analysis engines. The company offers a range of innovative products, including Viewinter.ai, a non-verbal behavior analysis tool designed to assist job seekers in training for video interviews. Additionally, Genesis Lab provides Genesis Drive, a solution that monitors driver drowsiness and distractions while detecting the emotions and behaviors of both drivers and passengers to enhance interactions and services. The Genesis Emotion AI SDK/API allows various industries to implement emotion recognition technology into their applications. The company also develops mobile applications, such as OREO, which humorously analyzes emotions, age, and gender from photos, and EMO, a gaming app that enables users to express emotions through facial mimicry. Overall, Genesis Lab aims to improve human-machine communication through its advanced AI technologies.
Genieworks
Series B in 2022
Genieworks is an innovative company focused on developing a software platform tailored for e-commerce, advertising, and online-to-offline (o2o) services. The platform uniquely integrates self-marketing capabilities, open market commerce, and on-demand car concierge services through a range of applications. This technology enables businesses to effectively engage in promotional marketing, build commerce networks, and develop smart tour technology-based solutions. By combining creative ideas with advanced technology, Genieworks aims to transform how businesses operate in the digital landscape.
Toffee Pie
Series B in 2022
Toffee Pie is a retailer of bras in different sizes. They develop bras of different sizes and shapes, enabling customers with different needs to access suitable underwear. They offer a large-cup underwear brand that researches and develops bras for big-breasted girls.
Jaranda Co., Ltd., headquartered in Seoul, South Korea, operates a digital platform that bridges the gap between teachers, parents, and students. The company's core business is to facilitate access to childcare and education services, addressing the challenge of information asymmetry in this sector. Jaranda's platform employs analytics to match students with compatible teachers, offers regular visit services, and provides lifecycle management, ensuring children and pre-teens receive appropriate education in a convenient manner.
Yibai Technology
Series B in 2022
Yibai Technology is a specialist in healthcare-based software-as-a-service.
Adriel is a marketing agency that specializes in optimizing digital marketing services through advanced artificial intelligence technology. The company offers a centralized platform that allows businesses to manage and enhance their digital advertising campaigns across various social media channels. By integrating key data and communication channels, Adriel enables clients to deliver a consistent promotional message while providing a user-friendly dashboard for easy campaign monitoring. With a focus on real-time insights and actionable suggestions, Adriel helps businesses identify high-performing advertising opportunities and adjust their strategies accordingly. Having served over 5,000 companies globally, Adriel caters to a diverse clientele, from small business owners to large corporations, helping them maximize their advertising potential and achieve higher returns on their investments.
Rizzle AI
Series B in 2022
Rizzle AI is a company that specializes in transforming text content and podcasts into engaging videos using advanced artificial intelligence technology. By leveraging professional images and natural-sounding voices, Rizzle helps businesses and publishers captivate audiences, expand their reach, and drive content monetization. The platform offers tools for easy video creation, custom thumbnails, short-form content, and interactive maps, making storytelling straightforward and impactful. Key differentiators include end-to-end simplicity in video production, access to premium media through partnerships with various high-quality providers, extensive syndication opportunities, and flexible service options tailored to individual needs. Rizzle AI's solutions are designed to streamline video production, allowing teams to focus on strategy, creativity, and revenue generation.
Dr.Diary is a company that specializes in developing a diabetes management application aimed at assisting users in monitoring and controlling their diabetes. Founded in 2017 and headquartered in Seoul, South Korea, the application allows users to track their blood glucose levels, record daily exercise routines, and receive reminders for medication intake. Additionally, it offers insights into how various foods affect blood sugar levels, thereby helping users make informed dietary choices. The platform includes features such as monthly health reports, daily tips for diabetes management, and communication tools that facilitate personal consultations with healthcare professionals. Through these services, Dr.Diary aims to empower individuals with diabetes to better manage their health and improve their quality of life.
Pin Therapeutics
Series B in 2022
Pin Therapeutics, Inc. is a biotechnology company founded in February 2017 and headquartered in South San Francisco, California. The company is focused on developing therapeutic products that harness protein degradation technology to target immune diseases, cancer, and aging-related conditions. Pin Therapeutics employs advanced screening systems, including its PinE3 platform for E3 ligase identification and the PinGLUE system for molecular glue degrader discovery. With a diverse team comprising experienced professionals from global pharmaceutical and biotech sectors, the company is actively advancing several programs, including selective molecular glue degraders and a PROTAC program. Through its innovative approaches to drug discovery, Pin Therapeutics aims to address critical unmet medical needs while enhancing the efficiency and specificity of protein degradation in therapeutic contexts.
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions and RISC-V Core intellectual property. The firm is recognized for pioneering platform-based system-on-chip (SoC) design, providing configurable domain-specific architectures and pre-validated key IP pools to streamline the development process. SemiFive collaborates closely with customers to translate innovative concepts into tailored semiconductor solutions, significantly reducing costs and risks associated with chip design. With robust partnerships, particularly with Samsung Foundry, it offers comprehensive end-to-end capabilities for various applications, including consumer and industrial Internet of Things (IoT), data centers, and artificial intelligence. This integrated approach enables faster realization of custom SoCs, catering to diverse client requirements efficiently.
MORAI Inc. is a technology company that specializes in developing a simulation platform for autonomous vehicles. Founded in 2018 and headquartered in Seoul, South Korea, with an additional office in San Francisco, California, MORAI creates a three-dimensional virtual environment that closely mimics real-world road conditions. This platform allows for the testing and enhancement of autonomous driving algorithms, providing valuable verification and validation solutions for automotive companies. Additionally, MORAI offers custom-built simulation services and datasets to support advanced algorithm development, helping self-driving car engineers and manufacturers effectively address scenarios that are challenging to replicate in real-world testing. By leveraging its artificial intelligence-enabled platform, MORAI aims to reduce the costs associated with verifying autonomous driving technology while enhancing overall response capabilities.
Loadcomplete
Series B in 2022
Loadcomplete is a South Korean developer of social and mobile games, founded in December 2009. The company specializes in creating engaging games for light-core to mid-core audiences, utilizing the latest technologies to foster a social gaming environment. Its notable titles include Tap Tap Heroes, Disco Panda, Bumping Bears, Play Kale, Trino, and Blue Heart, all available on iOS and Android platforms. Through its innovative approach, Loadcomplete aims to provide enjoyable gaming experiences that resonate with enthusiasts.
Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.
Yeoshin is a skin treatment information platform.
AIONCO KOREA
Series B in 2021
AIONCO KOREA Co., Ltd. is a logistics and air freight service provider based in Seoul, South Korea, established in 2015. The company offers a comprehensive range of services tailored for cross-border eCommerce clients, including competitive item sourcing, multi-channel fulfillment, drop shipments, global wholesale, and logistics solutions. AIONCO KOREA focuses on streamlining supply chains for brands engaged in both direct-to-consumer and wholesale markets. Its offerings also encompass warehousing, distribution logistics, and image production, ensuring a complete solution for managing logistics needs across various channels.
Spatial Systems, Inc. offers an augmented workplace platform designed to enhance communication and collaboration among users. Founded in 2016 and headquartered in New York, the company enables users to conduct meetings with spatial audio and 3D telepresence, facilitating a more immersive experience. Additionally, Spatial's platform allows for the sharing and organization of various digital content, including 3D models, videos, documents, images, and websites. The focus of the company is to transform how people work by creating a collective computing environment that fosters creativity and productivity. Spatial has attracted investment from notable firms and individuals, positioning itself as a leader in the augmented reality and virtual reality space.
Triple is a travel data services startup that operates a travel booking application aimed at connecting travelers with the tourism industry. The application facilitates the booking of hotels and restaurants while offering essential information such as weather forecasts, currency exchange rates, directions, translation services, time difference calculations, and recommendations for sightseeing spots. By providing these comprehensive resources, Triple enables travelers to explore new destinations without the stress of making extensive travel arrangements in advance.
OncoMyx Therapeutics
Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.
OncoMyx Therapeutics
Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.
PDC*line Pharma
Series B in 2021
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.
Otus is a healthcare institute that specializes in advanced eyecare system.
ONDA is a hospitality technology company based in Seoul, South Korea, specializing in reservation management solutions for small to mid-size hotels and guesthouses both locally and internationally. The company offers a suite of products, including ONDA Plus for reservation management, ONDA Wave for integrated scheduling, and ONDA Star, a comprehensive property management system. Additionally, ONDA Easysell serves as a hotel extranet platform to enhance distribution capabilities. With a focus on optimizing hotel operations and increasing online visibility, ONDA aggregates real-time data from over 40,000 properties and distributes it across 50 online channels, enabling hotels to expand their reach and boost bookings. The company also publishes Magazine ON, which features interviews with accommodation owners and industry insights.
Aulton New Energy
Series B in 2021
Aulton New Energy Automotive Technology Co., Ltd. specializes in developing battery swapping technology for electric vehicles in China. Headquartered in Shanghai, with an additional office in Guangzhou, the company manufactures equipment for quick battery exchanges and manages power stations that facilitate the installation of batteries in taxis and vehicles used for car-hailing services. Aulton also offers energy management services and has created an automated chassis replacement system that allows for the disassembly and installation of batteries in a fully automated environment, significantly reducing the time required for battery replacement to just a few minutes.
Immunobiome
Series B in 2021
Immunobiome is a biotechnology company focused on developing microbiome-based therapeutics aimed at treating challenging diseases, including cancer, autoimmune disorders, allergies, and neurological conditions. By leveraging advanced immunology, bioinformatics, and fundamental microbiome research, the company seeks to create innovative solutions that address conditions often deemed incurable. Its platform specializes in targeted treatments that can help manage intractable immune-related diseases and improve patient outcomes in various health challenges, including organ transplant rejections and inflammation-related issues.
Sellerhub
Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.
Bankware Global
Series B in 2021
Founded in 2010 and headquartered in Seoul, Korea, Bankware Global specializes in the development of banking and financial software systems tailored for various sectors, including retail, corporate, private, treasury, and microfinance banks. With a presence in three countries and four offices, the company serves over 100 financial institutions across seven countries in the Asia Pacific region. Bankware Global is recognized for its expertise in core banking solutions, having supplied its software to five digital banks in markets such as Korea, China, Japan, and Taiwan. The company is distinguished as a leading provider of core banking solutions in Korea, focusing on delivering innovative financial institution products and transaction software to both domestic and international clients.
Connecting
Series B in 2021
Connecting is a real-time voice-talk service company that focuses on facilitating meaningful conversations among individuals. It has developed a social calling application that allows users to define their preferences, including hobbies, age, region, and gender, to enhance the matching process. By leveraging a specialized algorithm, the application connects users with others who share similar interests and criteria, enabling them to engage in hassle-free conversations. This innovative approach aims to create a more personalized and fulfilling social interaction experience for its users.
Kilala has a product line of color pupils and its surrounding areas to meet the full range of needs of customers.
Eyevensys
Series B in 2021
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Cell in Cells
Series B in 2021
Cell in Cells is a biotechnology company focused on advancing regenerative medicine through its innovative cell therapy products. Utilizing advanced 3D technology, the company researches and develops novel biopharmaceuticals and cell therapies aimed at improving human health. By harnessing the potential of stem cells, Cell in Cells strives to create effective therapeutic solutions that enable medical professionals to treat a variety of diseases. The company's commitment to innovation positions it at the forefront of regenerative medicine, contributing significantly to the development of treatments designed to restore health and enhance patient outcomes.
Sky Labs is a technology company focused on developing innovative wearable devices for health monitoring, particularly a cuffless ring-type blood pressure monitor and a device known as the Cardio Tracker (CART). The CART is designed for continuous monitoring of atrial fibrillation, a common and often undiagnosed heart condition affecting many individuals over 40. This device can be worn comfortably on any finger and is both waterproof and dustproof, allowing users to wear it throughout their daily activities without interruption. It operates without user intervention, automatically detecting and recording atrial fibrillation, which users can track via a smartphone application. The device aims not only to assist individuals in managing their heart health but also to provide valuable data to healthcare professionals for accurate diagnosis. Sky Labs is currently conducting clinical trials in collaboration with Seoul National University Hospital to validate the performance of its technology, with an initial focus on the atrial fibrillation patient market in Finland, and an extended target market of millions worldwide. The company is also partnering with Bayer to explore further healthcare innovations.
WonderWall
Series B in 2021
WonderWall is an online art learning platform that connects artists and facilitates the sharing of practical knowledge across various creative disciplines. The platform provides access to a diverse range of online videos covering areas such as music, acting, directing, art, photography, design, and cooking. By offering these resources, WonderWall enables learners to acquire new skills and insights from the comfort of their homes, fostering a community of artists eager to enhance their craft.
Epibiotech
Series B in 2021
Epibiotech is a healthcare center that provides hair loss treatment solutions.
CONTEC is providing ground station services, satellite image processing, and application services. The company's ground station network supports VHF, UHF, S-Band, and X-Band frequencies for TT&C via high-performance receivers for high data rate reception. They especially focus on applications for urban change detection of smart cities and aim to provide the best service possible for local governments and therefore contribute to urban development. Contec's main goal of building a global ground station network and operating its own Earth observation satellites.
Modusign is an information technology company specializing in electronic contract services. It provides a web-based platform that facilitates the digital signing of contracts, streamlining the contract signing process and removing the necessity for in-person meetings. This innovative solution enables businesses to save both time and money, making contract management more efficient. By leveraging its technology, Modusign aims to enhance the overall experience of contract execution for organizations across various industries.
Onul-Hoi is a mobile commerce platform specializing in the same-day delivery of fresh fish products sourced directly from domestic fisheries. The company operates an online food delivery service that allows customers to order seasonal seafood and receive it on the same day. In addition to fresh fish, Onul-Hoi provides a selection of seafood dishes, ensuring a comprehensive offering for consumers seeking convenient and high-quality seafood options delivered to their homes.
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.
Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.
CHAI is a company focused on developing infrastructure technologies aimed at enhancing the efficiency of the digital economy. It offers a fintech platform that includes a debit card, a merchant-facing payment API, and an e-wallet that utilizes blockchain technology. This platform allows merchants and individual users to integrate a diverse array of payment options quickly and easily, often in less than an hour. Users can pay for items online by linking their bank accounts, streamlining the payment process. Through its innovative solutions, CHAI aims to facilitate seamless financial transactions and improve the overall digital payment landscape.
Humanscape
Series B in 2020
Humanscape, Inc. is a health-tech company based in Seoul, South Korea, founded in 2016. It specializes in developing blockchain software to collect and process health information from patients with rare and intractable diseases. By compiling comprehensive health data, including genotype, clinical, and phenotype information, Humanscape creates ready-to-use data sets that facilitate drug development. This systematic approach enables pharmaceutical companies and researchers to significantly reduce both the time and cost associated with developing new treatments. Through its innovative platform, Humanscape aims to improve the chances of cures for patients suffering from rare diseases, ultimately enhancing medical practices and treatment outcomes.
MegazoneCloud
Series B in 2020
MegazoneCloud, established in 2018 as a spin-off from Megazone Corporation, is headquartered in Seoul, South Korea. The company specializes in providing a wide array of cloud adoption and consulting services, including implementation, enterprise support, management, cost optimization, and education. With a strong partnership with Amazon Web Services and over 100 global technology partners, MegazoneCloud has built a reputation as the largest premier consulting partner of AWS in the Asia Pacific region. The company has successfully served more than 1,500 clients, including major enterprises such as Samsung, LG, and Lotte Group, by facilitating their digital transformation through tailored cloud solutions. Additionally, MegazoneCloud operates offices in Palo Alto, Tokyo, Shanghai, Hong Kong, and Hanoi, reflecting its commitment to expanding its global presence and supporting businesses in optimizing their processes and managing their cloud needs effectively.
Wave Corporation, founded in 2018 and based in South Korea, develops a mobile video chat application designed to enhance social interactions among users. The application enables individuals to create chat rooms where they can engage in group video chats, play live party games, watch video clips, read webtoons, and share photos. By facilitating these activities, Wave aims to reduce the distance between people, allowing friends to connect and interact in a more engaging and entertaining manner.
Prokarium
Series B in 2020
Prokarium Limited is a biopharmaceutical company based in London, United Kingdom, specializing in the development of vaccination and cancer immunotherapy solutions through synthetic biology. Established in 2007, Prokarium focuses on creating innovative microbial immunotherapy treatments, particularly in the oncology sector. Its product pipeline includes Vaxonella, which is designed to stimulate immune responses by utilizing the unique properties of the gastrointestinal tract. Additionally, the company is developing vaccines for various infectious diseases, including Clostridium difficile, Chlamydia trachomatis, plague, and enteric fever. Prokarium's lead program is aimed at revolutionizing the treatment of bladder cancer by fostering immune-driven, long-lasting antitumor effects, thereby offering new therapeutic options for healthcare providers in combating cancer and infectious diseases.
EVOS Esports
Series B in 2020
EVOS Esports is an eSports organization focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. The company provides essential infrastructure to support professional players and content creators, fostering an environment that promotes professionalism across various competitive gaming disciplines. EVOS Esports offers a comprehensive structure for its teams, which includes in-game coaching, dedicated training facilities, and mental wellness support. This commitment to player development and well-being positions EVOS Esports as a significant player in the rapidly evolving eSports industry.
Cashkaro is an Indian cashback and coupons site. They are backed by Mr. Ratan Tata and Indian VC firms, Kalaari Capital. With over two million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Nykaa, Ajio, etc.
Gaussian Robot
Series B in 2020
Gaussian Robot is a company based in Shanghai, China, that specializes in the development and manufacturing of commercial automatic sweeping robots. Founded in 2013, the company offers a range of products designed for various applications, including commercial cleaning robots, unmanned sanitation vehicles, security robot solutions, and building distribution robots. Additionally, Gaussian Robot provides autonomous positioning navigation modules to enhance the functionality of its robotic solutions. Through its innovative approach, the company aims to improve efficiency and effectiveness in commercial cleaning and service automation.
Hidden Sequence
Series B in 2020
Hidden Sequence is a production company specializing in drama content creation. It operates by producing and financing stage dramas, films, and television shows based on original scripts, featuring local talent. The company aims to cater to diverse artistic tastes through its varied offerings.
Grip is a mobile application that offers to sell products, update stories, go online and chat communication to sellers.
G2GBIO is a biotechnology company focused on improving medication administration and adherence for patients with chronic diseases. The company develops advanced controlled release drug products using proprietary technology, aiming to enhance the efficacy of medications for conditions such as diabetes and cancer. By prioritizing the supply of effective medicines, G2GBIO seeks to improve health outcomes for patients worldwide.
eBrace is a company focused on the research, development, and production of digital 3D printing technology specifically tailored for orthodontics. The firm specializes in creating innovative solutions for dental applications, including bracketless invisible appliances, customized lingual invisible appliances, and dentures. By leveraging advanced 3D printing techniques, eBrace aims to deliver precise and detailed dental products that meet the needs of both practitioners and patients.
Laundrygo
Series B in 2020
Laundrygo is an on-demand laundry service that offers subscription-based laundry cleaning solutions. The company focuses on delivering a convenient and efficient alternative to traditional laundry services by ensuring that customers receive their cleaned laundry within one day. By providing this rapid turnaround at a lower cost than conventional laundry shops, Laundrygo aims to enhance the customer experience and eliminate the hassle often associated with laundry tasks.
Medizen Humancare
Series B in 2020
Medizen Humancare, founded in 2012 and headquartered in Seoul, South Korea, is a research company specializing in genomic analysis to predict individual disease risks. The company offers services such as M-CHECK, which analyzes patients' genetic risk for specific diseases using gene chips or analysis kits, and MELTHY (DTC), a DNA analysis service. Medizen Humancare's work involves acquiring disease-specific genome contents, identifying new drug candidate genes, and developing preventive measures, with a focus on guiding disease prevention and extending healthy life spans through personalized genetic insights.
Rabbit Care
Series B in 2020
Rabbit Care is a financial services provider specializing in insurance and consulting. The company offers a diverse range of insurance products, including automotive, health, life, and corporate insurance. Through its digital platform and customer care center, Rabbit Care aims to deliver an exceptional customer experience and effectively meet the needs of its clients. By leveraging technology, the company enhances accessibility and efficiency in its service delivery, ensuring that businesses can satisfy customer expectations.
SecuLetter
Series B in 2020
SecuLetter Co Ltd is a company that specializes in cybersecurity solutions designed to combat a range of cyber threats, including malware and phishing attacks. Utilizing hybrid approaches that combine both static and dynamic analysis, SecuLetter effectively detects unknown attacks, even when cybercriminals attempt to conceal malicious links and attachments. The company focuses on diagnosing and analyzing security vulnerabilities at the assembly level of non-executable files, enabling it to achieve a high detection rate for security threats and exploits. SecuLetter's primary business areas encompass email security, secure data transmission between networks, web service file security, document centralization, cloud support security, and security threat intelligence, ensuring comprehensive protection against emerging cyber threats.
Pharos iBio
Series B in 2020
Pharos iBio Co. is a company focused on the development of innovative treatments for rare and intractable diseases. Utilizing a cutting-edge drug development platform that incorporates big data and artificial intelligence, Pharos iBio aims to address significant unmet medical needs. The company’s product pipeline includes several candidate drugs, such as PHI-101-AML for refractory or relapsed acute myeloid leukemia, PHI-101-OC for platinum-resistant or refractory ovarian cancer, and PHI-101-TNBC for metastatic triple-negative breast cancer. Additionally, Pharos iBio is advancing other candidates, including PHI-201, PHI-301, and PHI-501, as part of its commitment to improving patient outcomes in challenging therapeutic areas.
Longmao Data
Series B in 2020
Longmao Data is a Beijing-based company established in 2014 that specializes in providing data services for artificial intelligence platforms. The company focuses on collecting diverse forms of data, including images, texts, voices, and videos, which are then annotated through crowdsourcing. This annotated data is subsequently delivered to clients in the artificial intelligence sector, facilitating the training of their AI models. By offering comprehensive data solutions, Longmao Data plays a crucial role in enhancing the capabilities of AI technologies.
PDC*line Pharma
Series B in 2020
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.
Funda is a P2P finance service that connects multiple investors to sound stores that need funds and creates a financial service.
HappyEasyGo
Series B in 2019
HappyEasyGo is an online travel company based in India that specializes in providing affordable air ticket and hotel bookings. The platform enables users to purchase airline tickets from a variety of carriers, including IndiGo, Jet Airways, Go Air, SpiceJet, AirAsia, Vistara, and Air India, often at discounted prices. HappyEasyGo also offers promotions for advance bookings and features a low-cost search engine designed to help customers save on their travel expenses. Additionally, the company provides access to verified instant discount hotels, ensuring that travelers can find competitive rates for their accommodations.
Norma Inc. is a computer network security company based in Korea that specializes in cyber asset security and information asset security consulting services. The company focuses on providing comprehensive solutions to protect organizations from cyber threats, ensuring the integrity and confidentiality of their information assets. By leveraging advanced security technologies and expertise, Norma aims to address the evolving challenges in the cybersecurity landscape, helping clients enhance their security posture and mitigate risks associated with digital assets.
SecuLetter
Series B in 2019
SecuLetter Co Ltd is a company that specializes in cybersecurity solutions designed to combat a range of cyber threats, including malware and phishing attacks. Utilizing hybrid approaches that combine both static and dynamic analysis, SecuLetter effectively detects unknown attacks, even when cybercriminals attempt to conceal malicious links and attachments. The company focuses on diagnosing and analyzing security vulnerabilities at the assembly level of non-executable files, enabling it to achieve a high detection rate for security threats and exploits. SecuLetter's primary business areas encompass email security, secure data transmission between networks, web service file security, document centralization, cloud support security, and security threat intelligence, ensuring comprehensive protection against emerging cyber threats.
Ansun Biopharma
Series B in 2019
Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat severe human diseases. The company specializes in host-directed anti-viral therapies aimed at addressing respiratory viral infections, such as influenza and parainfluenza viruses, by targeting the host rather than the virus itself. Its product pipeline includes Fludase, which is designed for the prophylaxis and treatment of influenza-related respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fever caused by pathogens like Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a technology for creating microspheres and nanospheres for drug delivery. Founded in 2003 and originally named NexBio, Inc., the company rebranded to Ansun Biopharma in 2011, reflecting its commitment to addressing critical health challenges through advanced biopharmaceutical solutions.
Crowdworks
Series B in 2019
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.
HappyEasyGo
Series B in 2019
HappyEasyGo is an online travel company based in India that specializes in providing affordable air ticket and hotel bookings. The platform enables users to purchase airline tickets from a variety of carriers, including IndiGo, Jet Airways, Go Air, SpiceJet, AirAsia, Vistara, and Air India, often at discounted prices. HappyEasyGo also offers promotions for advance bookings and features a low-cost search engine designed to help customers save on their travel expenses. Additionally, the company provides access to verified instant discount hotels, ensuring that travelers can find competitive rates for their accommodations.
OncXerna Therapeutics
Series B in 2019
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.
Tapas Media
Series B in 2019
Tapas Media, Inc. operates Tapastic, an online platform and community designed for independent comic artists and visual storytellers. Founded in 2012 and based in San Francisco, the company provides a space for over 50,000 creators to publish serialized webcomics and novels, attracting more than 2 million unique monthly readers. Users spend a combined total of 70 million minutes on the platform each month, contributing to over 5 billion readings of stories to date. Tapas Media also collaborates with top creators to co-produce original intellectual properties that can be adapted into television series, films, games, or physical books. The platform's audience consists predominantly of female millennials, primarily located in the United States, and the Tapas app has surpassed 2 million downloads, ranking as one of the top-grossing comics apps on both iOS and Android.
GlowRoad is a social selling platform based in India that empowers women and small businesses to generate income through online and offline sales. Its mobile application facilitates a network of users, including housewives and students, who can promote and sell selected products within their local communities and social circles. By leveraging their personal networks, these resellers can earn money without the need for an initial investment, creating a secure and accessible means of entrepreneurship. GlowRoad's model focuses on enabling individuals to capitalize on social connections to drive sales, thus providing flexible earning opportunities in a supportive environment.
Hisense Bio
Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Triple is a travel data services startup that operates a travel booking application aimed at connecting travelers with the tourism industry. The application facilitates the booking of hotels and restaurants while offering essential information such as weather forecasts, currency exchange rates, directions, translation services, time difference calculations, and recommendations for sightseeing spots. By providing these comprehensive resources, Triple enables travelers to explore new destinations without the stress of making extensive travel arrangements in advance.
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, established in 2016. The company connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its innovative communication platform. Users can engage with medical professionals via video calls, voice calls, and chat, allowing for real-time consultations and health advice. Additionally, HaloDoc facilitates the ordering of laboratory tests that can be conducted at home, enhancing the convenience of accessing healthcare services. The platform aims to simplify and improve the healthcare experience for patients by providing easy connections to doctors, clinics, and hospitals, as well as offering medical delivery services through its partner pharmacies.
PR&D Company
Series B in 2019
PR&D Company designs and develops hey dealer app and website for car-selling services.